John Delyani

John joined Repertoire with more than 20 years of business and corporate development leadership experience at both small and large biotechnology and pharmaceutical companies. At Repertoire, John leads the corporate and business development function.

John was most recently at Tmunity Therapeutics, a T cell, solid tumor therapeutics company where he served as VP, Corporate Development. In this role John led business development and contributed to the development of the overall corporate strategy. Before he joined Tmunity he was the Executive Director of Business Development and Licensing at Merck, and prior to this role he was at Novartis where he was a member of the Novartis Institutes for BioMedical Research business development leadership team and led the search and evaluation group. Earlier in his career he had business development roles at Kalypsys and R&D and business development roles at Pharmacia. John received a PhD in Physiology from the University at Buffalo and an MBA from Maryville University of Saint Louis.